MARKET EYE-Indian shares edge higher; pharma stocks gain

Mon Nov 5, 2012 9:55am IST

Related Topics

Stocks

   

* The BSE index up 0.11 percent and the NSE index
 adds 0.13 percent.
* Indian stocks gain despite a fall in Asian shares on Monday
tracking a sell-off in global shares late last week, as
investors continued to shed risk ahead of the closely fought
U.S. presidential election and looked past strong U.S. jobs data
to fragile economic growth prospects worldwide.   
* Shares of Dr. Reddy's Laboratories gain 0.8 percent,
up for a sixth day. India's no. 2 drugmaker posted on Tuesday a
better-than-expected 32 percent rise in quarterly net profit.
 
* Cipla gains 1.8 percent ahead of its quarterly
earnings later in the day.
* Larsen & Toubro gains 0.5 percent on churning in
favour of large cap industrial stocks.

 (abhishek.vishnoi@thomsonreuters.com)
FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

India-WTO Standoff

India-WTO Standoff

India threatens to derail WTO deal, prompts angry U.S. rebuke  Full Article 

Economic Pulse

Economic Pulse

New govt promises low and stable tax regime for economic revival.  Full Article 

IPO Probe Ends

IPO Probe Ends

Facebook says SEC's IPO probe ends, extending WhatsApp closing date  Full Article 

World Stocks

World Stocks

Goldman Sachs downgrades stocks to neutral for short term  Full Article 

Disappointing Results

Disappointing Results

Amazon's far-reaching ambitions, lack of profits, unnerve investors  Full Article 

Global Growth

Global Growth

IMF cuts outlook, warns of stagnation risk in rich nations  Full Article 

Market Eye

Market Eye

Nifty retreats from record highs on profit taking.  Full Article 

Waning Enthusiasm

Waning Enthusiasm

Markets' post-election enthusiasm lost on consumers.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage